Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

NVCR holding history

NovoCure Ltd in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVCR overviewAll 13F holders of NVCRFull Q2 2026 holdings

Shares (Q2 2026)
157,235
Value
$2.38M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVCR by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026157,235$2.38M<0.1%+71,099+82.5%AddedHolders
Q1 202686,136$938.9K<0.1%−589,695−87.3%ReducedHolders
Q4 2025675,831$8.74M<0.1%+452,274+202.3%AddedHolders
Q3 2025223,557$2.89M<0.1%−670,591−75.0%ReducedHolders
Q2 2025894,148$15.9M<0.1%+573,420+178.8%AddedHolders
Q1 2025320,728$5.72M<0.1%+266,583+492.4%AddedHolders
Q4 202454,145$1.61M<0.1%+54,093+104,025.0%AddedHolders
Q3 202452$813<0.1%−516,811−100.0%ReducedHolders
Q2 2024516,863$8.85M<0.1%+128,524+33.1%AddedHolders
Q1 2024388,339$6.07M<0.1%−289,853−42.7%ReducedHolders
Q4 2023678,192$10.1M<0.1%+7,181+1.1%AddedHolders
Q3 2023671,011$10.8M<0.1%+119,275+21.6%AddedHolders
Q2 2023551,736$22.9M<0.1%+528,223+2,246.5%AddedHolders
Q1 202323,513$1.41M<0.1%+21,608+1,134.3%AddedHolders
Q4 20221,905$139.7K<0.1%−61,831−97.0%ReducedHolders
Q3 202263,736$4.84M<0.1%−351,888−84.7%ReducedHolders
Q2 2022415,624$28.9M<0.1%+67,647+19.4%AddedHolders
Q1 2022347,977$28.8M<0.1%+220,708+173.4%AddedHolders
Q4 2021127,269$9.55M<0.1%−4,785−3.6%ReducedHolders
Q3 2021132,054$15.3M<0.1%+20,505+18.4%AddedHolders
Q2 2021111,549$24.7M<0.1%+9,605+9.4%AddedHolders
Q1 2021101,944$13.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.